Home > Insider Trading > Filing (0001209191-22-020584)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645666	Kezar Life Sciences Inc.	KZR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1273885	M Franklin Berger	C/O Kezar Life Sciences, Inc. 4000 Shoreline Court, Suite 300 South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-03-18	15,000	$15.96	825,691	No	4	P	Direct
Common Stock	Acquisiton	2022-03-18	45,000	$17.00	870,691	No	4	P	Direct
Common Stock	Acquisiton	2022-03-21	20,000	$14.77	890,691	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.47 to$16.36 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3).
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.885 to $17.01 inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.44 to $15.00 inclusive.